MNX1 and hepatocellular carcinoma: Similarly, Ji et al. [15] demonstrated that MNX1-AS1 could also target miR-218-5p to increase COMMD8 level in hepatocellular carcinoma cells, consequently accelerating malignant cell growth, motility and invasion in vitro.